ACM
PFE icon

Allred Capital Management’s Pfizer PFE Stock Holding History

Allred Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$502K Buy
17,894
+166
+0.9% +$4.42K 0.18% 101
2025
Q4 		$441K Buy
17,728
+501
+3% +$12.6K 0.16% 110
2025
Q3 		$439K Buy
17,227
+148
+0.9% +$3.65K 0.15% 118
2025
Q2 		$414K Sell
17,079
-202
-1% -$4.71K 0.15% 112
2025
Q1 		$438K Buy
17,281
+98
+0.6% +$2.56K 0.18% 107
2024
Q4 		$456K Sell
17,183
-703
-4% -$19.1K 0.18% 114
2024
Q3 		$518K Sell
17,886
-522
-3% -$15.2K 0.2% 100
2024
Q2 		$515K Sell
18,408
-40
-0.2% -$1.1K 0.2% 105
2024
Q1 		$512K Sell
18,448
-383
-2% -$10.6K 0.2% 107
2023
Q4 		$542K Sell
18,831
-2,261
-11% -$68.3K 0.24% 92
2023
Q3 		$700K Sell
21,092
-7
-0% -$248 0.35% 60
2023
Q2 		$774K Buy
21,099
+98
+0.5% +$3.81K 0.38% 55
2023
Q1 		$857K Buy
21,001
+576
+3% +$24.9K 0.45% 51
2022
Q4 		$1.05M Buy
20,425
+387
+2% +$18.6K 0.57% 42
2022
Q3 		$876K Sell
20,038
-1,264
-6% -$61.4K 0.55% 44
2022
Q2 		$1.12M Sell
21,302
-720
-3% -$36.7K 0.7% 38
2022
Q1 		$1.14M Buy
22,022
+1,547
+8% +$80.3K 0.6% 43
2021
Q4 		$1.21M Sell
20,475
-1,248
-6% -$61.8K 0.58% 39
2021
Q3 		$934K Sell
21,723
-4,108
-16% -$182K 0.49% 53
2021
Q2 		$1.01M Sell
25,831
-357
-1% -$13.9K 0.5% 54
2021
Q1 		$949K Buy
26,188
+3,116
+14% +$111K 0.43% 56
2020
Q4 		$849K Sell
23,072
-3,454
-13% -$127K 0.46% 60
2020
Q3 		$923K Buy
26,526
+2,166
+9% +$75.9K 0.56% 49
2020
Q2 		$755K Sell
24,360
-942
-4% -$32K 0.48% 61
2020
Q1 		$783K Sell
25,302
-1,480
-6% -$50.4K 0.61% 48
2019
Q4 		$996K Sell
26,782
-2,021
-7% -$72K 0.54% 44
2019
Q3 		$968K Buy
28,803
+3,083
+12% +$112K 0.59% 47
2019
Q2 		$1.08M Sell
25,720
-220
-0.8% -$8.74K 0.62% 43
2019
Q1 		$1.06M Sell
25,940
-741
-3% -$29.7K 0.6% 48
2018
Q4 		$1.1M Buy
+26,681
New +$1.11M 0.74% 37

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Allred Capital Management's PFE Position: Q1 2026 in Review

Allred Capital Management increased its Pfizer (PFE) stake by 0.94% in Q1 2026, buying an estimated $4.42K and bringing the position to 17,894 shares worth $502K. The position accounts for 0.18% of the portfolio, ranked #101.

Allred Capital Management first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.21M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Allred Capital Management held 17,894 shares of Pfizer worth $502K as of Q1 2026.
  • Allred Capital Management bought 166 Pfizer shares in Q1 2026, an estimated $4.42K.
  • Pfizer made up 0.18% of Allred Capital Management's portfolio in Q1 2026, its #101 holding.
  • Allred Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Allred Capital Management's Pfizer position peaked at $1.21M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Allred Capital Management's 13F filing for Q1 2026, filed 14 May 2026.